State v. Miles

104 P.3d 604, 197 Or. App. 86, 2005 Ore. App. LEXIS 11
CourtCourt of Appeals of Oregon
DecidedJanuary 12, 2005
Docket0103-31747; A116636
StatusPublished
Cited by10 cases

This text of 104 P.3d 604 (State v. Miles) is published on Counsel Stack Legal Research, covering Court of Appeals of Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State v. Miles, 104 P.3d 604, 197 Or. App. 86, 2005 Ore. App. LEXIS 11 (Or. Ct. App. 2005).

Opinion

ORTEGA, J.

Defendant appeals a judgment convicting him of manufacturing a controlled substance, marijuana, contending that the trial court erred in barring him from asserting the “medical marijuana” defense provided in ORS 475.319(1) and the “choice-of-evils” defense provided in ORS 161.200. We affirm.

We review the record to determine whether defendant presented any evidence to support the defenses he sought to assert and evaluate that evidence in the light most favorable to defendant. State v. Brown, 306 Or 599, 605, 607, 761 P2d 1300 (1988).

In November 2000, police officers searched defendant’s residence and found dried marijuana, three small marijuana plants, smoking devices, and related paraphernalia, including grow lights. Based on that evidence, defendant was charged the following March with manufacturing a controlled substance.

Before trial, the state moved to preclude defendant from asserting the medical marijuana defense and the choice-of-evils defense. At an evidentiary hearing regarding those issues, defendant asserted — and the state does not dispute — that defendant suffers from several debilitating medical conditions that cause him significant abdominal and bladder pain and nausea. Although defendant takes several prescribed medications for those conditions, he maintains that the medications produce adverse side effects that marijuana does not produce and that the medications do not relieve his pain and nausea as effectively as marijuana does. He testified that at one point he went without marijuana for three months, but his symptoms grew more severe and he had to take more pain medication. Because he believes the pain medication is addictive, he prefers marijuana.

In December 1998 and again in June 1999, defendant asked his longstanding primary care physician, Dr. Zukowski, to write a letter recommending marijuana use for treatment of his symptoms. Zukowski declined on both [89]*89occasions and, according to defendant’s testimony, told defendant that marijuana was “not appropriate” for his medical condition and specifically advised him against using it. A gas-troenterologist and a urologist who treated defendant likewise declined to endorse defendant’s use of marijuana.

In April 2001 — several months after the search of his residence that led to these proceedings — defendant mailed a packet of materials to Dr. Leveque, an osteopathic physician and forensic toxicologist who testified that his practice was limited to “forensic toxicology and also to helping people get medical marijuana cards.” The packet contained defendant’s own written statement of his medical history and letters from two of his doctors describing his medical condition. Based solely on the written materials that defendant sent him, Leveque signed a statement supporting defendant’s application for a registry identification card provided for under ORS 475.309 as part of the Oregon Medical Marijuana Act (OMMA), which excepts medical use of marijuana from criminal prosecution under certain conditions. At the time of the hearing, Leveque had helped 890 people obtain their registry identification cards.

Defendant had not succeeded in obtaining a card at the time of the hearing in September 2001. He claimed that he had not applied for a card earlier because his doctors were “too paranoid” to fill out the physician’s statement necessary for an application and that his urologist had told him that Kaiser Permanente, his health insurance provider, had a policy not to allow physicians to sign such statements. However, Zukowski testified that Kaiser Permanente had no such policy. Defendant presented testimony from an additional medical expert who indicated, based on his review of defendant’s records, that it would be “appropriate and reasonable” for defendant to use marijuana for pain control in place of other medications. The trial court granted the state’s motions to preclude defendant from asserting the medical marijuana and choice-of-evils defenses, and defendant assigns error to those rulings.

We first consider the medical marijuana defense. With exceptions not relevant here, ORS 475.319(1) describes the defense, in pertinent part, as follows:

[90]*90“[I]t is an affirmative defense to a criminal charge of possession or production of marijuana * * * that the person charged with the offense is a person who:
“(a) Has been diagnosed with a debilitating medical condition within 12 months prior to arrest and been advised by his or her attending physician the medical use of marijuana may mitigate the symptoms or effects of that debilitating medical condition;
“(b) Is engaged in the medical use of marijuana; and
“(c) Possesses or produces marijuana only in the amounts allowed in ORS 475.306(1), or in excess of those amounts if the person proves by a preponderance of the evidence that the greater amount is medically necessary as determined by the person’s attending physician to mitigate the symptoms or effects of the person’s debilitating medical condition.”

(Emphasis added.) The only issue on appeal is whether defendant, as required under ORS 475.319(l)(a), was advised by his “attending physician” that marijuana may mitigate his symptoms. He contends that Leveque qualifies as an “attending physician” within the meaning of the statute. We reject that contention.

The OMMA defines an “[attending physician” for its purposes as “a physician licensed under ORS chapter 677 who has primary responsibility for the care and treatment of a person diagnosed with a debilitating medical condition.” ORS 475.302(1) (emphasis added).1 Leveque never examined defendant and never reviewed his medical records; indeed, he did not recognize defendant in the courtroom. All of his information about defendant’s condition came from letters written by defendant and his doctors. By contrast, Zukowski had treated defendant on a regular basis for more than a decade. Because Leveque did not have “primary responsibility” for defendant’s care and treatment, he does not qualify as defendant’s “attending physician” under the OMMA. Accordingly, defendant may not avail himself of the medical marijuana defense provided in ORS 475.319(1).

[91]*91We now turn to defendant’s second assignment of error, in which he asserts that he should not have been barred from asserting the choice-of-evils defense under ORS 161.200.2 ORS 161.200

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. Phillips
503 P.3d 1282 (Court of Appeals of Oregon, 2022)
City of Eugene v. Adams
495 P.3d 187 (Court of Appeals of Oregon, 2021)
State v. Dart
491 P.3d 813 (Court of Appeals of Oregon, 2021)
State v. Paul
410 P.3d 378 (Court of Appeals of Oregon, 2017)
State v. Dewhitt
368 P.3d 27 (Court of Appeals of Oregon, 2016)
State v. McPhail
359 P.3d 325 (Court of Appeals of Oregon, 2015)
State v. Luster
350 P.3d 575 (Court of Appeals of Oregon, 2015)
State v. Freih
348 P.3d 324 (Court of Appeals of Oregon, 2015)
State v. Dickens
348 P.3d 281 (Court of Appeals of Oregon, 2015)
State v. Joon Bum Ko
263 P.3d 1082 (Court of Appeals of Oregon, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
104 P.3d 604, 197 Or. App. 86, 2005 Ore. App. LEXIS 11, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-v-miles-orctapp-2005.